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INTRODUCTION
Carcinoma  cervix  is  one  of  the  leading  causes  of  death  of  female 
population in developing countries. By virtue of its accessibility, cancer of cervix 
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can be readily diagnosed even in its preinvasive stage. If treated in the earlier 
stages the patient can often be cured of the disease.
For each case of cancer of body of the uterus, there are 25 cases of cancer 
cervix in India. A close quarters observation on the social behavior of our society 
reveals that most of the women have their marriages at very early part of their 
life leading to early age at first intercourse and poor sexual hygiene which are 
considered to be important etiological factors for cervical carcinoma.
George Papanicolaou M.D.,  Ph.D. after whom the Pap smear is named 
laid the foundation for preventive medicine at its best. He correctly estimated 
cytology as an infant science destined to become a titan. In the same way there 
were  so  many  modifications  made  in  the  method  of  collection  of  specimen, 
techniques and methods of staining, interpretation and follow up.
The primary purpose of cervical cytology is to screen the population and 
identify the patients who have an abnormal pap smear. It has been the corner 
stone  of  cancer  cervix  screening  for  almost  50  years.  Despite  its  enormous 
success  as  preventive  screening  tool  for  cancer  cervix,  the  conventional  pap 
smear has its limitations.
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In the recent past, there has been emergence of various newer techniques 
to assess the proliferative capacity of cells. This has been an important criterion 
to assess the malignant behaviour of cells.
Various  techniques  are  available  like  DNA content  analysis,  ‘S’  phase 
fraction calculation by means of DNA cytometry, proliferating   antigens like C3, 
F10, DNA polymerase-2, Ki67 and PCNA. But these techniques are expensive 
and  can  be  carried  out  in  some  sophisticated  diagnostic  research  centers.  A 
simple and inexpensive method is  the staining and counting of the Nucleolar 
Organizer Regions. This is based on RNA transcription activity. Silver colloidal 
solutions of high concentration have been used for this purpose and this is called 
AgNOR stain. The number of AgNORS in a cell nucleus reflects the proliferative 
activity  of  the cell  with  progressive  increase  in  number from normal  cells  to 
dysplastic and carcinomatous cells. AgNOR in cervical cytology has also been 
studied. AgNOR though expensive, the single step technique and ease, which it 
can be done, is very impressive. Pap though less expensive than AgNOR is a 
cumbersome procedure with lot of chemicals involved.
The definitive diagnosis of the patient’s condition rests on the follow up 
histologic evidence from the biopsy material. Histologic diagnosis is frequently 
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used as a gold standard against which we calculate the accuracy of cytologic 
diagnosis.
Along with routine haemotoxylin and eosin staining in histopathological 
sections, AgNOR stain can be used. Studying the number, shape and distribution 
of AgNOR dots in the cell gives information not only about the morphology, but 
also about the behaviour of the cells. It is useful in differentiating doubtful cases 
of CIN.
AgNOR count  also  has  prognostic  significance.  CIN lesions  with  low 
AgNOR counts are more likely to regress in comparison to CIN lesions with high 
AgNOR  count.  So  it  can  be  used  as  an  adjunct  to  routine  cytology  and 
histopathology for diagnosis of cervical lesions in doubtful cases.
Hence the present study has been carried out with an attempt to correlate 
findings  between  cervical  cytology  and  histopathological  finding  of  biopsy 
cervix using Pap stain & AgNOR stain in cervical cytology and using H&E & 
AgNOR stain in histopathological sections.
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AIM OF STUDY
 To evaluate  Pap smears  in  patients  attending  the  Gynecology 
department of Government Rajaji Hospital, Madurai.
 To  study  abnormal  smears  and  subject  the  patient  to  biopsy 
study.
 To  correlate  the  cytological  findings  with  histopathological 
diagnosis.
 To assess the usefulness of the cytological study in the diagnosis 
of cervical lesions.
 To  evaluate  the  role  of  Argyrophilic  staining  of  nucleolar 
organizer regions in Pap smear and histopathological section of 
biopsy cervix.
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REVIEW OF LITERATURE
ANATOMY:
The cervix is the lower portion of the uterus which connects this organ to 
the vagina through the cervical canal. It is divided into a portion that protrudes 
into the vagina called portio vaginalis, and that lies above the vaginal vault called 
supra vaginal portion. Outer surface of portio vaginalis is known as the exocervix 
or ectocervix and the portion related to the endocervical canal corresponds to 
endocervix. The lower opening of the endocervical canal is known as external os. 
The upper limit of the endocervical canal is known as internal os.
 EMBRYOLOGY:
Cervix develops from the fused caudal portion of the Mullerian duct or 
Paramesonephric  duct  which  is  formed  by  the  invagination  and  subsequent 
fusion of the coelomic epithelium.
        The Epithelium of the Cervix is formed by the induction of basal cells from 
the underlying stroma which undergoes squamous differentiation. A portion of 
these cells remains uncommitted forming the reserve cells of the cervix. They are 
capable of both squamous and columnar cell differentiation.
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HISTOLOGY:
The  exocervix  is  lined  by  nonkeratinizing  squamous  epithelium  and 
composed of three layers.
1. Basal cell layer
2. Midzone (Stratum spongiosum)
3. Superficial layer.
The Endocervix is lined by tall mucin secreting columnar epithelium that 
is highly branched and form endocervical glands that extend at an oblique angle 
to the cervical canal into the lamina propria.
The junction between squamous and columnar epithelium is  known as 
squamo columnar junction. The position of the junction is variable due to both 
the cervical anatomy and the distribution of the basal and subcolumnar reserve 
cells that exist just cephalad of this junction. It is the progressive differentiation 
of  these  basal  /  reserve cells  that  governs  the  micro  anatomy of  this  region, 
ultimately resulting in the cephalad migration of the squamo columnar junction.
The  portion  of  the  columnar  epithelium that  is  ultimately  replaced  by 
squamous epithelium is termed the transformation zone. This is the site where 
precancerous  lesions  and  squamous  carcinomas  develop.  Koss  identified  that 
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more than 90 percent of intraepithelial lesions develop in the area of squamo 
columnar junction1. The remaining 10% of lesions are thought to originate from 
columnar epithelium. The  connective  tissue  in  the   lamina  propria of   the 
cervix  is   more  fibrous  with  blood  vessels  and   nerves . The smooth muscles 
of the muscularis extend into the cervix, but are not compact.
HISTORY AND MODIFICATIONS IN PAP SMEAR
  
While studying the hormonal   response of the human vaginal mucosa, 
George Papanicolaou, MD, Ph.D discovered that tumor cells could be found in 
vaginal fluid of women with cervical cancer2. 
Papanicolaou presented his paper entitled "New Cancer Diagnosis" at the 
Third  Race  Betterment  Conference  in  Battle  Creek,  Michigan,  in  19283. 
Unfortunately,  it  reached  only  a  limited  audience  and  came  at  a  time  when 
histologic techniques were being perfected and cytologic methods were on the 
wane.
Furthermore,  Aurel  Babès,  a  Romanian  pathologist,  published  a  paper 
entitled "The possibility of diagnosing uterine cancer by the smear technic" in the 
Proceedings  of  the  Conference  of  the  Gynecologic  Society  of  Bucharest  on 
January 23, 19274. 
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Babes elaborated on this paper in April 1928 and clearly stated that his 
method was applicable to early cancers that had not yet penetrated the stroma. 
Later, Babès made the statement that Kermauner and Schiller had used a 
modified vaginal smear method for the diagnosis of cervical cancer on a large 
scale with very good results5. 
Yet  ironically  the  feeling  at  that  time  (as  expressed  by  prominent 
oncologist  James  Ewing)  was  that  since  the  uterine  cervix  was  accessible  to 
biopsy, the use of a cytologic examination was superfluous. 
In 1943, the technique of diagnosing uterine carcinoma by cytology as 
well as the possibility of diagnosing early cervical cancer was accepted3. 
The  concepts  of  early  cancer  and  carcinoma  in  situ  were  widely 
understood and the potential of the ‘Pap smear’ for cancer prevention was finally 
appreciated. It was actually a Canadian physician, J. Ernest Ayre who described 
the method we know today as the Pap smear in the mid-1940s 6. 
Papanicolaou  had  studied  vaginal  pool  secretions  easy  to  obtain,  but 
tedious  to  screen.  Ayre  used  a  spatula  instead  the  ‘Ayre  spatula’  to  directly 
scrape cells from the cervix7. 
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In 1943 J.Ernest Ayre et al, emphasized the use of cervical os aspiration 
as a preferable technique for the diagnosis of uterine cancer and published ‘A 
simple  office  test  for  uterine  cancer  diagnoses.  Cervical  os  aspiration  was 
superior to vaginal aspiration because a greater concentration of malignant cells 
was found in the direct cervical smear, both in clinical and preclinical lesions. In 
1943 Papanicolaou and Marchetti used Cary’s spatula or glass syringe and took 
endocervical  and  endometrial  smear  and  studied. In  1947,  Ayre  et  al  used 
surface biopsy cell scrapping technique with Ayre’s spatula7.
A cervical   smear  or  liquid-based cytology  test  is  the  routine  test   for 
detecting  early  changes  in  the   cells  of  the  cervix.
THE BETHESDA SYSTEM 
Terminology  used  in  cervico /  vaginal  cytology  has  evolved  over  the 
course of years. Papanicolaou’s original system had five classes of increasing 
atypia. This system did not reflect the correct understanding of cervical neoplasia 
and  did  not  have  an  equivalent  in  tissues  diagnostic  terminology.  So  it  was 
eventually abandoned. It was progressively replaced by CIN systems in 1970. In 
1988, National cancer institute (NCI) working groups made uniform descriptive 
terminology for cervical cytology and named as ‘The Bethesda System (TBS)’. 
The  1988  Bethesda  system  of  reporting  cervix/vaginal  cytology  diagnoses 
13
divided squamous intra epithelial lesions into the following categories. 
1. Atypical squamous cells of undetermined significance (ASCUS)
2. Low Grade SIL
3. High Grade SIL
4. Squamous cell carcinoma
The main criticism   of this system was that it leads to over treatment of 
many individuals  whose smears were placed in Low Grade SIL category. So 
minor  modifications  were  incorporated  in  1991  Bethesda  system  which 
streamlined the terminology8. In addition, an adhoc committee developed criteria 
for  specimen adequacy and diagnostic  terms culminating  in  a TBS atlas  that 
outlines and illustrates the morphologic feature9. The Bethesda System (2001) is 
currently followed. 
The structure of The Bethesda System includes three factors namely,
a. Statement of specimen adequacy,
b. General categorization
c. Diagnostic terminology 
A. SPECIMEN ADEQUACY
An  adequate  specimen  is  described  in  positive  terms  as  one  that  is 
properly  labeled,  accompanied  by  relevant  clinical  information,  appropriately 
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fixed and on microscopic examination demonstrates an adequate number of well 
preserved,  evenly  distributed  evaluable  cells  reflecting  an  ectocervical  and 
endocervical component10.
Well preserved and well visualized squamous epithelial cells should cover 
more than 10% of the slide surface. An adequate endocervical / transformation 
zone component should at a minimum consist of two clusters of well preserved 
endocervical  and  /  or  squamous  metaplastic  cells.  Each  cluster  should  be 
composed of at least five cells11.
B. GENERAL CATEGORIZATION  
1. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY
 Infections:  Trichomonas  vaginalis,  fungal  organisms  like  candida, 
Actinomyces, Cellular changes associated with Herpes simplex virus.
 Reactive cellular changes.
The epithelia   covering   the   uterine ectocervix and endocervical canal 
are under the constant influence of   physiologic stimuli but also of ever changing 
external stimuli12.
Regenerative epithelial reactions are commonly found in patients   after 
partial  or  complete  destruction  of  epithelia  by  infection  and  inflammation. 
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Repair epithelium in experimental animals has been found to be more susceptible 
to the action of carcinogenic agents than non traumatized tissues13.
Regeneration  of  cells  as  a manifestation  of  a  reparative  change  can 
occur in squamous epithelium, squamous  metaplastic epithelium  and  columnar 
epithelium14.  Reparative reactions  are  frequent  in  patients  who  have had 
recurrent cervicitis and in patients who have had recent treatment such as  punch 
biopsies, conization, cryosurgery, laser therapy  and endocervical  curettage  This 
type  of  reaction is also  found  in  cases  of  erosion  cervix or ulceration of 
cervical  stroma  caused  by   prolapsed  uterus  or  by  an  IUCD.
In    cervical smear, cells   from   reparative   epithelium   appear   as sheet 
like   aggregates with   indistinct   cytoplasmic   boundaries.  The cells have a 
wide  variation  in  size  and  shape.  The  cytoplasm is  usually  cyanophilic  and 
sometimes finely vacuolated or may contain large vacuoles. Nuclei are mostly 
round  to  oval  with  some  nuclear  enlargement  and  variation  in  nuclear  size. 
Nucleoli are prominent and multiple macronucleoli are sometimes present. The 
nuclear chromatin is finely granular, almost always evenly distributed and not 
hyperchromatic. These  nuclear  changes  are  due  to  active  protein   synthesis 
in  the   fast  growing  cells  which  try  to  replace the damaged    epithelial 
cells.
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The  predominant  arrangement  of cells  in  sheet  like aggregates and 
normochromic, finely granular, evenly  distributed  chromatin  and the presence 
of  macronucleli  differentiate  the  cells  from reparative  changes and  cells from 
invasive  neoplastic  processes.  Some times,  it  may be difficult  to  differentiate 
between  both  of  them.  In  such  cases,  a  follow  up  smear  after  treatment  of 
infection will be useful in which the above changes will reverse back to normal 
study.
Inflammation causes minor cytologic abnormalities such as dual reaction, 
lysis or vacuolation of cytoplasm, slightly dispropotionate nuclear enlargement 
and an  increase  in  nuclear-cytoplasmic  ratio.  Regenerative  changes  of  nuclei 
such as folding of   nuclear membrane, karyorrhexis, karyolysis and pyknosis can 
also be seen.
Condylomatous   lesions   and   epithelial abnormalities
It has been recognized that certain intraepithelial neoplastic lesions of the 
human  cervix  first  defined  as  koilocytotic  warty  atypia  by  Koss  and  Durfee 
would now be diagnosed as condylomatous lesions caused by an infection with 
HPV15. HPV in particular the subspecies 6, 11, 16, 18, 31 and 35 were thought to 
be important sexually transmitted factors in the genesis of cervical cancer16. HPV 
types 6 and 11 are commonly associated with warty condyloma, flat condyloma 
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and  low  grade  dysplasia (CIN Grade 1) whereas  HPV  types  6, 18, 31 and 35 
are often  found in high grade lesions of CIN.
HPV affects both the nucleus and the cytoplasm of the infected cells .It 
causes peripheral condensation of the cytoplasm of these cells giving a wire loop 
appearance. The squamous angular forms tend to become rounded and the cell 
assumes  a  softer,  rounded  or  ovoid  appearance.  The  nucleus  is  most  often 
eccentrically placed with para nuclear halo in the intra cytoplasmic space. This 
type of cell is called Koilocyte. It has a high degree of specificity. Nearly 90% of 
cases of condyloma with koilocytic change were found to have demonstrable 
HPV antigen by immuno enzymatic technique.
2. EPITHELIAL ABNORMALITES
ASCUS  (ATYPICAL  SQUAMOUS  CELLS  OF  UNDERTERMINED 
SIGNIFICANCE)
          ASCUS reflects  the  reality  and limitations  of  light  microscopy  in 
classifying cytologic  changes.  It  should be  used sparingly  when morphologic 
changes exceed the parameters of a benign reactive process but are insufficient 
for a definitive diagnosis of a malignant lesion.
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There is nuclear enlargement of squamous cells with mature superficial/ 
intermediate  type  cytoplasm.  Nuclear  enlargement  is  two and a  half  to  three 
times  that  of  a  normal  intermediate  squamous  nucleus,  but  the  chromatin 
remains evenly distributed without significant hyperchromasia. Nuclear outlines 
are smooth and regular.
Atypical squamous cells associated with atrophy should be considered if 
cells  show  nuclear  enlargement  with  concomitant  hyperchromasia,  marked 
irregularities  in  nuclear  contour  or  chromatin  distribution  or  marked 
pleomorphism in the form of tadpole or spindle cells. 
Atypical  squamous  cells  with  metaplastic  cytoplasm  showing  nuclear 
enlargement  about  one  and  half  to  two  times  normal  raises  the  differential 
diagnosis of reactive metaplasia versus HSIL. In low risk population, the rate of 
ASCUS should be less   than 5%. In high risk population the rate of ASCUS may 
be higher, but should not exceed two to three times the rate of SIL.
Correlation  of  ASCUS cases  with  the  results  of  biopsy,  correlation  of 
ASCUS  cases  with  HPV  typing,  review  of  ASCUS  cases  by  a  second 
cytopathologist  and calculation of  ASCUS /  SIL ratio are the various quality 
assurance  monitors  for  ASCUS.  In  25%  to  60  %  of  patients  with  ASCUS, 
however further evaluation will detect a squamous intraepithelial lesion17. 
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SQUAMOUS INTRA EPITHELIAL LESIONS (SIL)
In TBS, low grade squamous intraepithelial lesion (LSIL) and high grade 
squamous intra epithelial lesion (HSIL) encompass the spectrum of precursors to 
squamous  carcinoma  of  the  cervix.  LSIL  incorporates  changes  of  human 
papilomavirus (HPV) as well as mild dysplasia/CIN I18. HSIL includes moderate 
dysplasia /CIN2, severe dysplasia /CIN3 and carcinoma insitu / CIN3.
Diagnosis  of  LSIL  based  on  cellular  changes  associated  with  HPV 
requires  nuclear  as  well  as  cytoplasmic  abnormalities.  Nuclear  changes  may 
include enlargement with hyperchromasia, a pyknosis with chromatin smudging 
and wrinkling of nuclear contours. Cytoplasmic changes consist of a well defined 
perinuclear  cavity,  associated  with  peripheral  thickening  of  the  cytoplasm or 
cytoplasmic  orangeophilia  and  rounding  of  cellular  contours.  LSIL  changes 
typically involve ‘mature’ intermediate or superficial type cytoplasm with well 
defined polygonal borders19.
         Features that favour a high grade lesion include increased numbers of 
abnormal cells, higher nuclear to cytoplasmic ratios, greater irregularities in the 
outline of the nuclear envelope and nuclear chromatin distribution and increased 
number of  chromocentres.  The cells  of  HSIL have a  more  immature  type of 
cytoplasm either delicate or lacy with rounded cell border.
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This  two  tiered  LSIL  /  HSIL  approach  attempts  to  morphologically 
distinguish minor from significant lesions.
MILD DYSPLASIA (CIN I OR LOW GRADE SIL)
CYTOLOGY
Cells from mildly atypical lesions such as mild dysplasia (CIN grade 1) 
usually  have  plentiful  clear  translucent  cytoplasm  with  well-defined  angular 
borders. Cells resemble intermediate and superficial type squamous cells with a 
somewhat reduced cytoplasmic body and a slightly enlarged nucleus, occupying 
less  than  one  third  of  the  total  area  of  the  cell.  Nuclear  chromatin  is  finely 
granular, evenly distributed and only slightly hyperchromatic20.
HISTOLOGY
          The upper two thirds of the epithelium usually show a relatively regular 
arrangement of cells, with preserved stratification. These layers are composed of 
cells recognizable as intermediate type and superficial squamous type cells with 
slightly  reduced  cytoplasmic  volume  and  slightly  increased  nuclear  size. 
Aberrations of nuclear morphology are predominantly limited to the most basal 
layers of the epithelium.
21
MODERATE DYSPLASIA (CIN II OR HIGH GRADE SIL) 
CYTOLOGY 
Most cells are round to oval, but spindle cells and elongated and bizarre 
shapes may occasionally be found. Cytoplasmic staining is cyanophilic,  but a 
relatively  high  number  of  the  cells  may show eosinophilia  of  the  cytoplasm. 
Nuclei  are  enlarged  and  round  to  oval,  sometimes  elongated  or  irregularly 
shaped.  Nuclear  chromatin  is  evenly  distributed  and  slightly  too  moderately 
hyperchromatic.  Nucleoli  are  usually  absent.  The  nuclear/cytoplasmic ratio  is 
increased21.
HISTOLOGY
       Only  the  upper  one  third  of  the  epithelium still  shows  evidence  of 
stratification of cells. Cell arrangement is disturbed in as much as two thirds of 
the thickness of the epithelium.
SEVERE   DYSPLASIA (CIN GRADE III OR HIGH GRADE SIL)
CYTOLOGY
         The size of  the cells  in severely abnormal intraepithelial  changes is 
comparable with the parabasal cell type. Cytoplasm is usually sparse, typically 
forming  a  small  rim around the  nucleus.  Cells  are  seen singly  as  well  as  in 
aggregates.  The   nucleus  usually  occupies  at  least  two  thirds  of  the  total 
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area of the cell. Nuclei have a hyperchromatic irregularly distributed, coarsely 
granular  chromatin.  Some  severe  dysplasias  show  an  extreme  irregularity  in 
shape and size of the composing cells.
HISTOLOGY
In severe dysplasia, cells show a greatly disturbed arrangement in all the 
three  layers  of  the  epithelium.  Throughout  the  entire  epithelium,  cells  show 
reduced maturation with loss of cytoplasmic volume and an increased nuclear 
size and shape and often have irregular forms.
CARCINOMA   IN SITU
Carcinoma  in situ  is  used  to   describe  a  lesion   replacing  the  normal 
surface  epithelium  or  the  epithelium  of  the  invaginations  of  the  surface 
epithelium or both, in which all the layers of the epithelium are composed of 
abnormal poorly differentiated or largely undifferentiated cells22.
CYTOLOGY     
Cells occur singly or as syncytial aggregates with indistinct cell borders. 
Cells have only a minimal amount of cytoplasm.  Nuclei vary in size and shape 
and frequently overlap. Nuclear chromatin is irregularly distributed and coarsely 
granular. 
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HISTOLOGY
Irregular  arrangement of cells and almost complete lack of maturation. 
Most superficial layers show parakeratosis. Mitosis can be seen at all levels with 
absence of invasion.
INVASIVE CANCER OF THE UTERINE CERVIX
CYTOLOGY
Cells are often arranged in syncytial masses in which cells have indistinct 
boundaries.  Round or  oval  forms  are  more  numerous.  Large  round  and oval 
nuclei  with  slightly  irregularly  distributed  nuclear  chromatin  and  irregular 
macronucleoli. Cytoplasmic eosinophilia is more often observed.        
ATYPICAL  ENDOCERVICAL  CELLS  OF  UNDETERMINED 
SIGNIFICANCE
This  category  includes  a  broad  morphologic  spectrum  ranging  from 
atypical  appearing  reactive  processes  all  the  way  to  adenocarcinoma  in  situ 
(AIS).Therefore lesions falling into this category should be further  subclassified, 
if   possible,  according  to  whether  a  reactive  or  a  premalignant  /  malignant 
process  (AIS) is   favored.
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ATYPICAL ENDOCERVICAL CELLS, PROBABLY REACTIVE
These cells demonstrate nuclear enlargement three to five  time’s normal 
and slight hyperchromasia. A honeycombed pattern with distinct cell borders is 
often maintained.
ATYPICAL ENDOCERVICAL CELLS, PROBABLY AIS
These cells are characterized by cellular strips and rosettes demonstrating 
elongated, overlapping  nuclei  with  moderately  coarse  chromatin  and 
hyperchromasia.  The  peripheral  border  of  the  glandular  clusters  may  be 
‘feathered’ with protruding nuclei, in contrast to the smooth communal border 
typical of glandular fragments.
ADVANCES IN SPECIMEN COLLECTION AND INTERPRETATION:
SPECIMEN COLLECTION
Attempts to optimize the specimen itself for screening and interpretation 
have  been  made.  The  thin  prep  (cytyc,  Marlborough)  method  has  been 
introduced to improve the quality of specimen collection. Specimens are placed 
in a collection fluid that homogenizes and rinses the cells. The sample suspension 
is then used to create a series of thin prep slides, with cells concentrated in a 
20mm2 areas.  This  method  tends  to  optimize  cell  preservation  and  reduce 
artifacts  that  hinder  interpretation.  In  one  study  of  251  patients,  excellent 
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correlation between the standard Pap smear and the thin prep was noted23. Slides 
could be read faster, from a smaller sample area, and with fewer numbers of cells 
needed to make the correct diagnosis. 
          Computerized   screening systems have been created24. PAPNET  is  a 
neural  network  computer  processing  system  that  screens  conventionally 
prepared  slides. The  computer  is  programmed  in pattern  recognition  and  is 
able  to  identify abnormalities based on morphologic characteristics .From the 
computer review, selected abnormal cells are shown in 128 video images, 400x 
magnified  fields  with  their  corresponding  grid  location  from  the  slide.  The 
images are then reviewed by a cytologist to interpret the finding on the screen. 
Areas of concern on review are then confirmed by examination of the actual 
slide. 
PAPNET system  could retrospectively  identify  intraepithelial  lesions 
missed on  routine cytology  from  19  to 20   patients  who  developed biopsy 
proven,  high-grade   or invasive lesions. Others  have  reported  a   2.2%  false 
negative  rate  reduction  with  PAPNET  in  a  series  of  638  smears.
ADJUVANT TESTS
              A  variety  of  adjuvant  tests have  been  introduced   to  improve  the 
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sensitivity   and  specificity   of   cervical     cancer   screening   and  to  provide 
prognostic  information. These tests include  HPV detection,  new techniques  for 
visualizing   acetic-acid –stained  cervical  specimens,  and  molecular  markers.
The  association of  HPV types  16,18,31,  and  35  with  high-grade dysplasia 
and  cancer  has  led  to  HPV  tests. With improvements in technology, HPV 
testing has become widely available. It has been used both in primary screening 
and in triaging patients into risk groups.  
           Molecular markers are being developed for the detection of cervical 
dysplasia or prediction of progression. Different molecular markers are expressed 
in    normal,  premalignant  and  malignant  tissues.  One  such  marker,  the  MN 
antigen   is  a  protein  expressed  in  dysplastic  and  malignant  cervical  tissue25. 
AGNOR STUDIES
Cell  kinetics  plays  an  important  role  in  tumour  behavior.  Proliferation 
rates of the tumour can be assessed to determine the behavior of a particular 
tumor.  The  cell  cycle  can  be  divided  into  four  phases  based  on  the  nuclear 
chromatin activity. They are, S.G1, G2 and G0 phases. The cells show active 
reduplication of  DNA in the S Phase.  G2 is  the  second resting phase before 
active mitosis. Thus the DNA content at the end of "S" phase is an indicator of 
proliferative activity. AgNOR detects the DNA content at this stage.
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Stable cells are quiescent cells in G0 Phase and can be stimulated into G1 
by  an  appropriate  stimulus.  The  tumour  suppressor  gene  p53  blocks  the 
progression of cells through the cell cycle late in the G1 phase of replication. 
Mutant forms do not have this effect.
During the phase of active DNA replication, strips of DNA containing 
RNA genes are seen inside the nucleolus.  These DNA fragments are actively 
transcribing  with  the  help of  polymerase  1  enzyme.  These  are  considered as 
ribosomal factories. Cell cycle is controlled by a few enzymes called M Phase 
promoting factors.
The precise localization of NOR, has been found to be in the 18S DNA 
gene clutter in the stalk region. However, exceptions do occur.
An increase in the number of AgNORs counted in any given section could 
be explained as follows:
1. Increase  in  the  number  of  AgNOR  bearing  chromosomes  in  the 
karyotype.
2. Increase in transcriptional activity producing more visible argyrophilic 
cells.
3. Increase in the proliferating rate of cells resulting in large population 
showing positivity.
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4. Tumours with increased AgNOR counts in interphase nuclei are more 
likely attributable  to  cellular  proliferation than to  N ploidy  because 
diploid  cells  are  tetraploid  in  G2  phase  transiently,  resulting  in 
temporary  doubling  of  NOR  bearing  acrocentric  chromosomes  as 
found by  Crocker et al (1989)26 Immediately before and after mitotic 
division, the NORs disperse and then re-aggregate leading to increase 
in the number of countable AgNORs in the nuclei.
John Crocker et al, in 1990 enumerated standardized approach in counting 
AgNOR. Firstly all silver stained structures could be counted but when lying in 
groups each cluster (almost aggregated or partly disaggregated nucleoli) treated 
as one structure. Secondly, where AgNOR could be counted within a nucleolus 
each AgNOR could be counted as unit together with the smaller AgNOR seen 
outside the nucleus over all  he suggest that total AgNOR dots both intra and 
extra nucleolar be enumerated26.
In 1995 D. Prathiba et al studied the value of AgNORs in premalignant 
and malignant lesions of the cervix. The mean AgNOR count found to increase 
progressively from normal to CIN I, II, III, and invasive carcinoma27.
In 1997, Calore et al conducted a study of organizer nucleolar regions by 
the  argyrophil  technique in  cervical  intra  epithelial  neoplasms and found that 
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AgNOR  counting  can  be  useful  in  the  identification  and  classification  of 
individual  cases  of  intraepithelial  neoplasia  and  their  differentiation  from 
eventual difficult cases of cervicitis28. 
In 1997, Jyotima Agarwal et al found that mean AgNOR was higher in 
CIN and Malignant lesions, when compared to squamous metaplasia and chronic 
cervicitis.  And also adenocarcinomas have higher AgNOR when compared to 
squamous and adenosquamous carcinoma29.
In 1998, Terlikowski S et al compared AgNOR counts of CIN III  and 
SCC  and  suggested  that  AgNOR  counts  could  be  of  significance  in  the 
evaluation of cervical lesions and could elaborate histopathological diagnosis30.
In 2001 J.S. Misra et al performed an assessment of AgNOR count as 
tumor  marker  in  cervical  carcinogenesis  in  cervical  smears.  The  statistical 
analysis revealed significant variation between normal and inflammatory smears. 
There was highly significant variation between inflammatory, LSIL, HSIL and 
frank malignancy smears31.
In  1999,  Kurian  et  al  studied  the  relation  between  cervical  glandular 
intraepithelial neoplasia to micro invasive and invasive adenocarcinoma of the 
30
uterine cervix32. 
In 2001, Sakai Y et al had done morphometric evaluation of nucleolar 
organizer regions of intra epithelial neoplasia. They found that number of cells 
with one dot decreased with increasing CIN and the number of cells with more 
dots increased with increasing CIN. Total number of dots per 100 cells increased 
with increasing CIN and concluded that counting cells with 4 or more dots is the 
parameter for distinguishing the grade of CIN33. 
In 2003, Rajini Kawshik et al found AgNOR as a reliable indicator of cell 
proliferation and malignant potential of the lesion and can be used as an adjuvant 
in routine histopathology in cervical lesions34.
ADVANTAGES OF PAP SMEAR
• No injury to tissue is produced allowing frequent sampling to know the 
progress of the disease or regression of the lesion
• Smears cover a wider surface area than that involved in a biopsy.
• Intimate cellular details are more often clearly seen in an isolated cell of a 
smear because of the minimum shrinkage and distortion in such cells.
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• Smears  permit  a  better  evaluation  of  the  nature  of  inflammation  or 
infection.
• Special stains can always be used as they are used in tissue sections.
• Changes due to irradiation and other forms of therapy are easily evaluated.
LIMITATIONS OF PAP SMEAR
• The  interpretation  of  the  morphological  cellular  changes  is  based 
mainly on individual observation and often cannot be forced into rigid 
criteria. This interpretation is sometimes subjective.
• The cytologic diagnosis is not always final. It must often be confirmed 
by histopathology. 
• The  cytologist  bases  the  diagnosis  on  the  study  of  minute  cellular 
details, while the histopathologist mainly examines the tissue pattern. 
• The location of the lesion cannot be pinpointed by cytology. 
• The interrelation and arrangement of the cells cannot be established.  
• Neighboring cell in a smear often originate from different parts of the 
organ. 
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• The relation of the cells to the supporting stroma which is important in 
the diagnosis of an invasive carcinoma compared with carcinoma in 
situ cannot be determined by cytology.
• The size of the lesion cannot be appreciated by cytology because the 
number of exfoliated cells has little correlation to the size of the lesion. 
• The exfoliated cells may not represent the true nature of the lesion. 
Poorly differentiated cells for example are the only cells exfoliating 
from neoplasm with mixed components. 
• The screening of a smear can be time consuming and often the nature 
of the lesion is not obvious as in a histopathological section. The type 
of  the  lesion  like  in  situ  as  compared  with  early  invasion, 
adenocarcinoma or sarcoma is more difficult to determine by a smear.
ADVANTAGES OF AgNOR STAINING
• Single step modified colloidal silver technique is easy to do than the 
cumbersome procedure of pap stain which involves a lot of chemicals. 
• It can be used on archival as well as fresh material. 
• It can be observed in smears, squash cytology and histopathological 
sections. 
• It does not require any special fixative or complex apparatus.
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LIMITATIONS OF AgNOR STAINING
• The  counting  procedures  adopted  are  manual  and  hence  long  and 
tedious.  Observer  error  is  the  major  cause  of  inaccuracy  and 
inconsistency. 
• The dots  of  AgNOR interphase  nuclei  need  not  always  correspond 
actively to the  number of  such types  in  the  karyotype as  found by 
Underwood and Giri 199835. 
• Overlap and coalescence may result in misjudged counts as mentioned 
by Crocker J et al26. The chemicals used in AgNOR stain are costly 
when compared to that of pap stain.
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MATERIAL AND METHODS
  
The present study has been carried out in the Department of Pathology, 
Madurai Medical College and Madurai, India for a period of 2 years from June 
2005 to May 2007.
           The  cytological  materials  were obtained  in  the  form  of  smears  which 
were   fixed in  95% alcohol  for pap  and  AgNOR  staining . Details of the 
patients  such  as  age  at  marriage,  parity,  contraception  and  symptoms  were 
recorded in the working proforma which is appended in the annexure 1.
PAP STANING:
Materials required:
• Harris hematoxylin was prepared using potassium alum and mercuric 
oxide  and  filtered  into  a  dark  bottle  for  storage.  The  working  solution  was 
replaced every 1 to 3 weeks, depending on the number of slides being stained.
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• OG 6
Orange G 1.0% solution in 95% Alcohol  - 100ml.
Phosphotungstic acid - 0.015gm.
• EA 36
Light green SF yellowish - 0.14% in 95% alcohol - 45ml.
Bismark brown Y-0.5% in 95%   Alcohol                    - 10ml.
Eosin yellow -0.55% in 95% alcohol                   - 45ml.
Phosphotungstic acid                                         - 0.2 gm.
Lithium carbonate, saturated aqueous solution   - 1 drop.
PROCEDURE
1. Slides were transferred directly from the fixative, without drying, to 
95%  alcohol,  and  brought  down  through  70  and  50%  alcohols  to 
distilled water.
2. Slides were stained   in Harris hematoxylin for 5 minutes.
3. And gently rinsed briefly in distilled water. 
4. They were dipped in 0.25%Hcl in 50% ethanol (acid alcohol) about six 
times for 20 seconds.
5. And placed in running tap water for 6 minutes.
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6. They were rinsed in distilled water and run through 70% 80% to 95% 
alcohol.
7. And stained in OG 6 for 3 minutes..
8. Rinsed in two changes of 95% alcohol.
9. Stained in EA 36 for 3 minutes.
10. Rinsed in three changes of 95% alcohol.
Dehydrated  in  absolute  alcohol,  followed  by  equal  parts  of  absolute 
alcohol and xylol, cleared in xylol and mounted. The smears were analyzed and 
the  cellular  details  were  evaluated  under  light  microscopy.  The  results  were 
entered  in  the  working  proforma  in  the   annexure -1 under  The  Bethesda 
System   and  WHO  formulation. 
Each of the samples was then subjected to an argyrophilic staining for the 
nucleolar organizer region according to the modified colloidal silver technique of 
Crocker et al26.  
AgNOR STAIN 
PREPARATION OF STOCK SOLUTION
SOLUTION   A
1ml of formic acid was dissolved in 99ml of distilled water and a 1% 
solution of formic acid was made. Two grams of gelatin powder was dissolved in 
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100ml of 1% formic acid by agitation and warming up to 60 degree centigrade. 
This comprised stock reducing solution.
PREPARATION OF SILVER SOLUTION
SOLUTION B
A  50%  solution  of  silver  nitrate  was  prepared  by  dissolving  2gm  of 
crystalline silver nitrate in 4 ml of distilled water.
PREPARATION  OF  THE  SILVER  COLLOIDAL  STAINING 
SOLUTIONS
4ml of freshly prepared solution B   was mixed with 2ml of the stock of 
solution A and immediately used.
STANING PROCEDURE
1. The smears were layered with 50% silver nitrate in 2% gelatin formic 
acid solution.
2. The slides were then incubated in dark room for 40 minutes at room 
temperature.
3. The slides were then washed in distilled water dehydrated cleared and 
mounted in D.P.X. mountant.
AgNOR SCORE
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The stained slides  were  viewed under  oil  immersion and intra  nuclear 
silver dots are hand counted making use of light microscope. After counting at 
least 100 cells, AgNOR score was calculated; i.e., mean number of   AgNOR 
dots per nucleus. The count was repeated by another person to minimize observer 
error.
Three main types of AgNOR configuration could be described in normal 
or neoplastic cells. They are depicted in the diagrams 1 to 3.
In diagram 1, the NORs are fully aggregated to form a solitary, rounded 
argyrophil structure, often called an AgNOR but corresponding to the nucleolus.
Diagram 2 shows a nuclear pattern which is often seen in proliferating 
cells where NORs can be seen within the nucleolus.
Diagram  1:  TWO  RESTING  LYMPHOCYTES  SHOWING  ONE  OR  TWO 
NUCLEOLI
Diagram 2: A TUMOR CELL SHOWING AgNORs WITHIN THE NUCLEOLI 
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Diagram 3: A MALIGNANT CELL SHOWING AgNORs LYING FREE IN THE 
NUCLEUS 
Diagram 3 represents the distribution of small true AgNORs throughout 
the nucleoplasm as frequently observed in highly malignant cells26.
There   are two approaches   to count AgNORs:
Firstly all silver stained structures could be counted but when laying in 
groups; each cluster was treated as one structure. [Type 1 method]
Secondly, where  AgNORs  can be separately seen within a nucleolus, 
each AgNOR  could  be counted as  a  unit,  together with the smaller  AgNORs 
seen  outside  the  nucleolus  [type  2   method].  A  type  2  method  had  been 
followed in our study.
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It had   been observed that type 2 method of counting have higher AgNOR 
scores than type 1 method of counting. The mean AgNOR count per nucleus was 
also graded   for each case.
HISTOPATHOLOGY
The  histopathology    specimens  of  cervix  biopsy  were  fixed  in  10% 
formalin.  The  tissue  slices  were  processed, paraffin, blocked, 5 microns   thin 
sections  were  cut  and  stained  by  Hematoxylin  and  Eosin  as  described  by 
Bancroft  in  Theory  and   Practice  of  Histological  Techniques37. The unstained 
slides   of   tissue  section were  immersed in  distilled water   for  10 minutes, 
deparaffinised and  AgNOR  stain was done on those slides as  described  earlier 
and  AgNOR count was done.
 The  results  of  histopathological  study of H  and E  stained sections  and 
AgNOR  count of AgNOR  stained  sections were entered in the  proforma.
The information collected regarding all the selected cases were recorded 
in  a  Master  Chart.  Data  analysis  was  done  with  the  help  of  computer  using 
Epidemiological Information Package (EPI 2002).
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Using this software, frequencies, and percentage, range, mean, standard 
deviation, x2 and 'p' values were calculated. A 'p' value less than 0.05 is taken to 
denote significant relationship.
Sensitivity,  specificity,  accuracy, positive predictive value and negative 
predictive values were calculated using the following formulae and taking HPE 
findings as the Gold standard.
Sensitivity =            True positive         x 100
True positive + false negative
Specificity =                      True negative             x 100
False positive + true negative
Accuracy = True positive + True negative x 100
         Total number of cases 
Positive predictive value =            True positive                     x 100
                                             True positive + False positive
Negative predictive value =            True negative               x 100
True negative + False negative
Photomicrographs  of  the  smears  and  sections  were  taken  wherever 
needed.
42
PHOTO MICROGRAPHS
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Fig 1.Polymorpho nuclear leukocytes, squamous cells and cluster of 
degenerated basal cells in reactive smear, Pap stain x 100 (785/05)
Fig 2ASCUS ,Cells show nuclear enlargement and even chromatin with 
superficial type cytoplasm , Pap stain x 450 (2020/05)
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Fig 3.LSIL cells with mature intermediate type cytoplasm, fine nuclear chromatin 
and well defined angular cell border, Pap stain x 100 (739/06)
   
Fig 4.HSIL cells with high N/C ratio, irregular nuclear outline and nuclear 
chromatin distribution. Pap stain x 100 (1990/06)
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Fig 5.Malignant cell clusters with cells having indistinct cell boundaries and 
large irregular hyperchromatic nuclei, Pap stain x 100 (1387/06)
Fig 6. Cluster of malignant cells of adeno carcinoma, 
Pap stain x 100 (1619/06)
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Fig 7. Ag NOR count of 3.7 in a reactive smear by TBS, AgNOR stain 
X 1000 (1273/05)
Fig 8. AgNOR count of 4.8 in a smear which showed LSIL in TBS. AgNOR 
stain x 1000 (1043/05)
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Fig 9. AgNOR count of 5.8 in a malignant cluster. AgNOR stain 
X 1000 (1780/05)
Fig 10. Chronic cervicitis with inflammatory infiltrate in the stroma, H&E 
stain x 450 (G2193/05)
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Fig 11. Squamous metaplasia. Columnar epithelium of endocervix replaced 
by squamous epithelium H&E stain x 450 (3298/05)
Fig12  Mild dysplasia with koilocytic changes H&E stain x 450 (G4472/06)
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Fig 13. Moderate dysplasia, altered cell arrangement and nuclear changes 
limited to lower 2/3, H&E stain X 450 (G1938/05)
  
Fig 14. Carcinoma in situ, all the layers of epithelium involved, H&E Stain
 X 450 (G931/05)
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Fig15. Well differentiated SCC showing malignant squamous cells in sheets 
with keratinisation, H&E stain x 450 (2963/05)
Fig16. Moderately differentiated SCC with malignant squamous cells in 
Sheets, H&E stain X 45 (G4495/06)
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Fig 17.Poorly differentiated SCC.H&E stain x 450(G121/06)
Fig 18. Adenocarcinoma with glandular pattern, H&E stain, 
X 450 (G 4111/06)
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Fig 19. Malignant squamous cells in sheets with glandular elements-
Adenosquamous carcinoma, H&E stain x 450 (G2846/05)
Fig 20. Pattern of AgNOR staining in squamous metaplasia, AgNOR
  Stain X 450 (G3298/05)
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Fig 21. AgNOR pattern in carcinoma in situ, AgNOR stain x1000,(G841/05)
Fig 22. AgNOR count 6 in SCC, AgNOR stain x 1000(4455/06)
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OBSERVATOIN AND RESULTS
In  the  two year  study period from June 2005 to May 2007,  3842 pap 
smears were received from Government Rajaji Hospital, Madurai. Among these 
smears, 220 abnormal smears were identified and they were categorized under 
The Bethesda System.
Out  of  220  smears  studied,  reactive  cellular  changes  were  80 
(36.4%).Atypical  squamous  cells  of  undetermined  significance  were  53 
(24.1%).Low grade squamous intra epithelial lesions were only 2 (0.9%). 
High grade squamous intra epithelial lesions were 33 (15%). Squamous 
cell carcinoma was 44 (20%). Atypical endocervical cells were only 1 (0.5%). 
Atypical endocervical cells favour neoplastic were 5 (2.3%) and endocervical 
adenocarcinoma in situ were 2 (0.9%). [Table 1 and Diagram 4]
          The histopathological examination of biopsy cervix results of the above 
smears  were  compared  and  analysed.  In  the  histopathological  examination 
results, non neoplastic lesions were 97 (44.1%), pre malignant lesions were 40 
(18.2%) and malignant lesions were 83 (37.7%). 
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            Among these 97 non neoplastic lesions, 91 (94%) were chronic cervicitis. 
One (1%) was endocervical polyp, 4(4%) were metaplasia and one (1%) was TB 
cervicitis.  
TABLE 1
PAP SMEAR REPORT: TBS
PAP Smear report No. %
Reactive cellular changes 80 36.4
Atypical squamous cells of undetermined significance 
(ASCUS) 
53 24.1
Low grade squamous intra epithelial lesions (LSIL) 2 0.9
High grade squamous intra epithelial lesions (HSIL) 33 15
Squamous cell carcinoma (SCC) 44 20
Atypical endocervical cells (AEC) 1 0.5
Atypical endocervical cells favour neoplastic 5 2.3
Endocervical adeno carcinoma in situ 
(EAC in situ)
2 0.9
Total 220 100
DIAGRAM - 4
PAP SMEAR REPORT - TBS
80
532
33
44
1 5 2
REACTIVE ASCUS LSIL
HSIL SCC AEC
AEC FAVOUR NEOPLASTIC EAC IN SITU
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Among  40  premalignant  lesions,  14  (35%)  mild  dysplasia,  one  (3%) 
moderate dysplasia and 25 (62%) severe dysplasia with carcinoma in situ were 
detected.
The  total  number  of  malignant  lesions  was  83.  Out  of  these,  well 
differentiated  squamous  cell  carcinoma  were  20  (24.5%),  moderately 
differentiated  SCC were  45 (54.5%)  poorly  differentiated  SCC were  6 (7%) 
adenosquamous were  5 ( 6%) and adenocarcinoma 7 (8%) [Table 2 and Diagram 
5].
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TABLE – 2
INCIDENCE OF MALIGNANT LESIONS
HPE results Number Percentage
Well Differentiated SCC 20 24.5
Moderately Differentiated SCC 45 54.5
Poorly Differentiated  SCC 6 7
Adenosquamous Carcinoma 5 6
Adeno Carcinoma 7 8
Total 83 100
DIAGRAM - 5
INCIDENCE OF MALIGNANT LESIONS
5 (6%)
6 (7%)
45(54.5%)
20(24.5%)
7(8%)
Well Diff SCC Mode Diff SCC Poorly Diff SCC
Adenosquamous Adeno Ca
AGE INCIDENCE
Age  group  started  from  21  upto  75  was  included  in  the  study.  Age 
between 21 to 30 years were 33(15%), 31 to 40 years were 66(30%), 41 to 50 
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years were 69(31.4%), 51 to 60 years were 34(15.5%) and more than 60 years 
were 18(8.2%) [Table 3].
AGE AT MARRIAGE
In our study, cases with age at marriage 18 and below 18 were 148 (673) 
and between 19-30 were 72 (32.7) [Table 4]
PARITY
In   this  study, nulliparous  women  were 2(0.9%), para 1 were  7(3.2%), 
para 2  were 78(35.5%), para  3  and above  were  133(60.4%) [Table 5]
 
SYMPTOMS
          164(74.5%) cases presented with white discharge whereas 52(23.6%) 
presented  with  bleeding  p/v.  And  only  4  cases  (1.9%)  presented  with  mass 
descending  p/v.  So  the  commonest  and  early  symptom was  excessive  white 
discharge p/v [Table 6]. 
TABLE 3
AGE
Age Group (in years) No. %
< 20 - -
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21-30 33 15
31-40 66 30
41-50 69 31.4
51-60 34 15.5
>60 18 8.2
Total 220 100
Mean
S.D.
44.1
11.5
TABLE - 4
AGE AT MARRIAGE
Age at marriage
(in years)
No. %
< 18 148 67.3
19-30 72 32.7
Above 30 - -
Total 220 100
Mean
S.D.
18.8 yrs
4.0 yrs
TABLE 5
PARITY
Parity No. %
Nulliparus 2 0.9
1 7 3.2
2 78 35.5
3 & >3 133 60.4
Total 220 100
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TABLE 6
SYMPTOMS
Symptoms No. %
White discharge 164 74.5
Bleeding p/v 52 23.6
Mass descending p/v 4 1.9
Total 220 100
CYTOLOGICAL EVALUTION OF PAP SMEARS REPORTS
           During this study period, 220 abnormal adequate smears with cellular 
changes were received. They were stained, evaluated and categorized under TBS.
Under TBS, 80 (36.4%) were with reactive cellular changes. The cells had 
cyanophilic  cytoplasm and round  to  oval  nucleus  with  fine  chromatin  in  the 
background  of  degenerated  basal  cells  and  polymorpho  nuclear  leukocytes. 
(Fig.1).
ASCUS cases were 53(24.1%) The criteria for ASCUS were the nuclear 
enlargement  with evenly distributed chromatin and superficial  or  intermediate 
type cytoplasm (Fig 2).
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LSIL were 2 (0.09%) with enlarged hyperchromatic nucleus, intermediate 
type cytoplasm and well defined cell borders in cytology (Fig 3) and HSIL were 
33  (15%)  in  which  there  were  increased  number  of  cells  with  high  nuclear 
cytoplasmic ratio,  irregular  nuclear  outline and nuclear  chromatin distribution 
(Fig 4). 
44  (20%)  cases  were  SCC,  in  which  cells  were  arranged  as  syncytial 
masses.  The  cells  had  indistinct  cell  boundaries  with  large  irregular 
hyperchromatic nuclei.  (Fig 5) one case (0.5%) of atypical endocervical cells, 
5 (2.3%) cases of atypical endocervical cells favour neoplastic. There are 2 cases 
(0.9%)  of  adenocarcinoma  in  situ  in  cytology  with  pallisading  of  columnar 
tumour cells (Fig 6).
WHO grading was done for 136 smears. WHO grade I were 50 (36.7%), 
WHO grade II were 2 (1.5%) and WHO grade III and above were 84 (61.8%). 
           When the AgNOR dots on pap smears were analysed, 2.1 to 3 were 
29 (13.2%) and 3.1 to 4 were 71 (32.3%), 4.1 to 5 were 54(24.5%), 5.1 to 6 were 
26 (11.8%), 6.1 to 7 were 22(10%) and more than 7 were 18(8.3%).
          In this study, mean AgNOR score for reactive lesions was 3.1 (Fig7), 
ASCUS was 4.6 LSIL was 4.8 (Fig 8),  HSIL was 4.9,  SCC was 5.8 (Fig 9) 
atypical endocervical cells was 4.8, atypical endocervical cells favour neoplastic 
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was 5.5 and endocervical adenocarcinoma in situ is 7.1. Malignant cases have 
higher AgNOR than reactive cases [Table 7 and Diagram 6].
TABLE 7
AgNOR IN CYTOLOGY 
PAP Smear results AGNOR - PAP
Mean
Reactive cellular changes 3.1
ASCUS 4.6
LSIL 4.8
HSIL 4.9
Squamous cell carcinoma 5.8
Atypical endocervical cells 4.8
Atypical endocervical cells favour neoplastic 5.5
Endocervical adeno carcinoma in situ 7.1
DIAGRAM – 6
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AgNOR IN CYTOLOGY 
HISTOPATHOLOGICAL DIAGNOSIS
Out of  220 cases,  91cases  (41.4%) belonged to  chronic  cervicitis  with 
inflammatory infiltrate in the stroma (Fig 10). One case  was endocervical  polyp 
(0.5%) and one(0.5%) was tuberculous  cervicitis. 4 cases (1.8%) were squamous 
metaplasia  in  which  the  endocervical  columnar  epithelium  was  replaced  by 
squamous  epithelium.(Fig. 11) 14(6.4%) cases were  mild dysplasia in which the 
nuclear  changes  were  limited  to  the  basal  layers  of  epithelium (Fig  12)  and 
1(0.5%) case  was  moderate  dysplasia with cellular nuclear changes limited to 
two thirds of thickness of epithelium. (Fig 13) Severe  dysplasia with  carcinoma 
in  situ were 25 (11.4%)  where all the layers were affected by abnormal tumour 
cells  with  intact  basement  membrane  (Fig.  14)  well  differentiated  SCC with 
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keratinization (Fig. 15) were 20 (9.1%), moderately  differentiated  SCC with 
malignant  squamous  cells  in  sheets  (Fig.16)  were  45  (20.5%),  poorly 
differentiated  SCC (Fig. 17) were 6 (2.7%), adenocarcinoma (Fig. 18)  were 
7(3.1%), adenosquamous carcinoma with malignant squamous cells in sheets and 
glandular elements  (Fig. 19 ) were 5(2.1%). [Table -8 and Diagram – 7].
TABLE 8
HPE RESULTS
HPE Results No. %
Chronic cervicitis 91 41.4
Endocervical polyp 1 0.5
Tuberculous cervicitis 1 0.5
Metaplasia 4 1.8
Mild dysplasia 14 6.4
Moderate dysplasia 1 0.5
Severe dysplasia with 
carcinoma in situ
25 11.4
Well differentiated SCC 20 9.1
Moderately differentiated SCC 45 20.5
Poorly differentiated SCC 6 2.7
Adeno carcinoma 7 3.1
Adeno squamous carcinoma 5 2.1
Total 220 100
DIAGRAM - 7
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HPE - RESULTS
93(43%)
45(20.5%)
5(2.1%)7(3.1%)6(2.7%)
20(9.1%)
4(1.8%)
25(11.4%) 1(0.5%) 14(6.4%)
C C / EP / T C M ILD  D YSP LA SIA M OD ER A T E D YSP LA SIA
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M OD E.D IF F .SC C P OOR LY D IF F .SC C A D EN O C A R .
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When   the AgNOR  dots  were  analysed  in  silver  colloidal solution 
stained   220  histopathological  sections,   the   AgNOR  count   of  1.1   to  2 
category   were  3(1.4%) and 2.1  to  3  were  24  (10.9%), 3.1  to  4  were 
64(29.10%).  4.1 to 5 were 42 (19.1%).  5.1  to  6  were   28(12.7%)   6.1  to  7 
were  34(15.4%)  and  more than 7 were 25(11.40%). 
In our study there is no significant difference in AgNOR counts between 
squamous  metaplasia  (Fig  20)  and  chronic  cervicitis  The  mean  number  of 
AgNORs per nucleus is significantly higher in dysplasia (mild 4.9, severe 5.5) 
and  malignant  lesions  (squamous  cell  carcinoma  6,  adeno  carcinoma  6.4)  as 
compared to metaplasia (3.3) and chronic cervicitis (3.2) [Table 9 and Diagram 
8]. 
TABLE 9
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AgNOR IN HPE
HPE results AGNOR HPE
Mean
Chronic cervicitis 3.2
Metaplasia 3.3
Mild dysplasia 4.9
Moderate dysplasia 5
Severe dysplasia with carcinoma in situ 5.5
SCC 6
Adeno carcinoma 6.4
Adeno squamous carcinoma 6.6
DIAGRAM - 8
3.2 3.3
4.9 5
5.5 6
6.4 6.6
0
2
4
6
8
AgNOR HPE
Chronic Cervicitis Metaplasia 
Mild Dysplasia Moderate Dysplasia
Severe Dysplasia SCC
Adenocarcinoma Adeno Squamous carcinoma
All carcinomas and severe dysplasia (Fig. 21) have significantly higher 
AgNOR counts per nucleus compared to reactive lesions. NOR counts are higher 
in  adenocarcinoma  when  compared  to  squamous  cell  carcinoma.  Statistical 
analysis reveals significant difference between mean AgNOR counts of chronic 
cervicitis and dysplasia; mild dysplasia and severe dysplasia,  severe dysplasia 
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and invasive carcinoma, squamous cell carcinoma (Fig.22) and adeno carcinoma.
Overall the mean AgNOR counts for carcinoma cervix are increased from 
chronic cervicitis to dysplasia.
CYTOHISTOPATHOLOGICAL CORRELATION 
Out  of 80    reactive  cellular changes  detected, 75(93.8%)cases  were 
reported as chronic cervicitis in histopathological diagnosis, 3(3.8%) cases  were 
squamous metaplasia, one(1.3%)  case was mild dysplasia and one(1.3%) case 
was moderately differentiated  SCC. 
53 smears belonged to ASCUS category. Their histopathological follow 
up showed 18 (34%) chronic cervicitis, 12 (22.6%) mild dysplasia, 8 (15.1%) 
severe dysplasia with carcinoma in situ, 1(1.9%) squamous metaplasia, 7 (13.2) 
well differentiated SCC, 7(13.2%) moderately differentiated SCC. That is among 
53 smears, 19 were reactive lesions, 20 were preinvasive lesions and 14 were 
malignant lesions.
2 smears belonged to LSIL category among which one (50%) turned out 
to be mild dysplasia and another (50%) severe dysplasia with carcinoma in situ.
         33 smears belonged to HSIL category which in HPE showed one (3%) 
moderate  dysplasia,  16  (48.5%)severe  dysplasia  with  carcinoma  in  situ,  8 
68
(24.2%) well differentiated SCC, 7 (21.2%) moderately differentiated SCC and 
one (3%) poorly differentiated SCC.
Out of 52   malignant  cases  detected   in  cytology  all  of   them  were 
found  out  to  be malignant in  HPE  sections   also.
Table  10  illustrates  the  correlation  obtained  between  cytological  and 
histopathological   diagnosis.
Coming to the evaluation of efficacy of pap smear test,
True positive cases were 122,
False positive cases were 19,
True negative   cases were 77,
False negative cases were 2.
So  the  overall  sensitivity  was  90%, specificity was 80% accuracy  was 
90% and  positive predictive  value  was 87 [Table 11 and Diagram 9].
TABLE 11
EFFICACY OF PAP SMEAR TEST
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True 
positive
False 
positive
True 
negative
False 
negative
Sensitivity Specificity Accuracy PPV NPV
122 19 77 2 90 80 90 87 97
DIAGRAM - 9
90
80 90
87
97
0
20
40
60
80
100
SENSITIVITY SPECIFICITY ACCURACY PPV NPV
EFFICACY OF PAP SMEAR TEST
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DISCUSSION
This  study  is aimed  at  finding out  the efficacy  of  pap  smear  in 
detecting  malignant  lesions  of  cervix  in the  preinvasive  stage  and the 
usefulness  of  the adjuvant  AgNOR  stain in  the    detection  of  that  lesion.
AGE GROUP
In   our  study the age  group  of  21 to  30 are  33 (15%), 31  to  40  are 
66 (30%)  and   41  to   50   are  69 (31.4%),  51  to  60   are  34 (15.5%)  and 
more than  60  are 18 (8.2%) with higher age incidence noted in fifth decade.
In  British   Columbia   study  1990, the  age group  of   15  to  18  were 
27%, 20  to 34 were  68%, 35 to 59 were 46% and 60 and above were 21% with 
highest age incidence noted in third and fourth decade38.
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The  mean  age  of  the  patient  increases  as  the  severity  of  the  lesion 
increases. The  mean  age  of  chronic  cervicitis  is 38.8,  where  as  that  of  mild 
dysplasia   is 40,  severe  dysplasia  is 48   and  malignant   lesions  are  more 
than   47.  Shalini et al showed that 32 year was the mean age of patients with 
benign pathology in their study. 
Dysplasia  was  found  to  be  more  common  between  20  and  39  years. 
Kushtagi and Fernandes in their study showed the prevalence of dysplasia was 
higher in women over 30 years39.
          Among malignant lesions, mean age of well  differentiated SCC cases are 
47.9 years, moderately differentiated SCC are 50 years and poorly differentiated 
SCC are 53.7 years in our study.
Squamous cell carcinoma was found to be more common between 40-and 
60 years. Shalini et al showed 25% of well differentiated and 35% of moderately 
differentiated carcinomas in the age group 40-49, 50% of well differentiated and 
57% of moderately differentiated carcinoma was in age group > 50. The mean 
age of patient with cancer cervix was 4140.
AGE AT MARRIAGE
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In our   study,  among  220  cases, 148(67.3%)   are  married  at or below 
the age of 18 and  72[ 32.7%]  cases are married  between 19 to 30. So it is clear 
that   cervical  lesions   are more  common  in  early  age  of  marriage  and  early 
age of intercourse which expose the genital tract to various pathogenic organisms 
like  HPV, physical and chemical  trauma . 
Incidence of squamous cell  carcinoma was about 50% in patients with 
marital life more than 20 years. Kushtagi et al had demonstrated that increase in 
severity of underlying CIN lesions occur with increase in the duration of years of 
marital life39.
PARITY
Out  of  220 cases, 2 are (0.9%) nulliparous while para1 are 7 (3.21%), 
para 2 are 78 (3.5%)  para 3 are 76 (34.5%)  and  para  more  than 3  are 57 
(25.9%).
The   mean parity  for  reactive  lesions  is  2.9, pre malignant lesions is 
2.9 and  malignant  lesions  is 3.1 in the  smear  results. The mean parity for 
reactive lesions was 2.6 where as 3 for premalignant lesions and 3 for malignant 
lesions in HPE results.
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        Malignant cases have high parity than the other cases.  So this relationship 
is  statistically    significant.   Multiparity  is  one  of  the  etiological  factors  for 
cervical lesions. Various family planning methods usually adopted by the women 
modify  the  status  of  parity  which  should  be  kept  in  mind  when  there  is 
significantly increasing incidence of premalignant and malignant lesions in low 
parity groups. 
In this study, there are 2 (0.9%) nulliparous women with cervical lesions. 
Pattern  et  al  reported  a  prevalence  of  0.98%  cervical  lesions  in  non  gravid 
women41. A study by Shalini et al showed the mean parity was 4.2 in patients 
with invasive cancer. Kushtagi and Fernandez showed that the prevalence of CIN 
was significantly higher in parity of more than 2. This might be attributed to 
hormonal and nutritional changes that occur in pregnancy, immuno suppression 
during pregnancy and cervical trauma during vaginal delivery42.
CYTO HISTOPATHOLOGICAL CORRELATIONS
80 cases cytologically show reactive cellular changes. In the correlative 
histopathological study of these 80 cases, 73(91.2%)show chronic cervicitis, one 
(1.25%)  is  tuberculous  cervicitis,  one  (1.25%)  is  endocervical  polyp  and  3 
(3.8%) with squamous metaplasia, one case (1.3%) with reactive cellular changes 
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show mild dyplasia and another case (1.3%) show moderately differentiated SCC 
[Table – 10].
53 cases belong to ASCUS category. In histopathological correlation, 18 
(34%) show chronic cervicitis, 1(1.9%) show squamous metaplasia, 12(22.6%) 
show mild dysplasia,  8(15.1%) show severe dysplasia with carcinoma in situ, 
7(13.2%)  show  well  differentiated  SCC  and  7(13.2%)  show  moderately 
differentiated SCC. That is 19 reactive lesions,  20 preinvasive lesions and 14 
malignant lesions are found. So we detected 8 preinvasive lesions from ASCUS 
category  which  is  very  beneficial  to  the  patient  regarding  prognosis. 
Premalignant  lesions  need  further  follow  up  by  repeat  smears,  colposcopy 
directed biopsy if available or cone biopsy.
2 cases belong to LSIL category among which one (50%) turned out to be 
mild dysplasia and another (50%) severe dysplasia with carcinoma in situ. 
Among  220  cases,  33  are  HSIL  category.  Their  histopathological 
correlative study show one (3%) moderate dysplasia, 16(48.5%) severe dysplasia 
with carcinoma in situ, 8(24.2%) well differentiated SCC,7(21.2%) moderately 
differentiated SCC and 1(3%) poorly differentiated SCC.
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44  out  of  220  smears  are  SCC  category.  In  HPE,  5(11.4%)  well 
differentiated  SCC,  30(68.2%)  moderately  differentiated  SCC 4(9.1%)  poorly 
differentiated  SCC and 5 (11.4%)  adenosquamous  carcinoma.  In  all  cases  of 
histopathologically  proved  malignancies,  smears  showed  positivity  for 
malignancy.
         Only one smear show atypical endocervical cells which turned out to be 
adeno carcinoma in HPE. Atypical endocervical cells favour neoplastic is seen in 
5 smears and all of them are histopathologically proved to be adenocarcinoma. 
There are 2 cases of adenocarcinoma in situ in cytology in which one of them is 
adenocarcinoma and another one is adenosquamous carcinoma.
Coming to the efficacy of Pap smear, the sensitivity is90%. Specificity is 
80.2%and  accuracy  is  90%.  In  Jones  B.A  et  al  study  sensitivity  is  89.4%, 
specificity is 64.8% and accuracy is 88.9%43 [Table 12].
TABLE 12
COMPARATIVE STUDY – PAP SMEAR AND HPE
Present study 
Percentage
Jones BA Study 
Percentage
Sensitivity 90 89.4
76
Specificity 80 64.8
Accuracy 90 88.9
False negative are 2 cases which are due to error in sampling, screening or 
interpretation of smears. Tritz et al found discrepancies between cytologic and 
histologic diagnoses in 69 out of 615 (11%) patients with a cytologic diagnosis 
of neoplastic abnormality Source of error may be inappropriate biopsy or faulty 
biopsy44. 
Small size of the tumour cells and their scarcity in smears are the major 
sources of false negativity45. Adhesion of cells within the abnormal epithelium is 
another reason for false negativity. 
There are 19 false positive cases in our study. It may be due to inadequate 
biopsy or misinterpretation of benign process. Anderson and Jones documented 
patients with abnormal smears and initial lack of confirmation by biopsy require 
long term follow up to discover occult neoplastic lesion46. False positivity may be 
due to removal of entire lesion by energetic brushing resulting in biopsies with 
denuded surface or misinterpretation of cluster of endocervical cells with large 
nuclei and nucleoli, cluster of endometrial cells or postmenopausal atrophic cells 
as abnormal cells.
AgNOR STAINING IN PAP SMEAR
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In this study,  mean AgNOR score for reactive lesions is 3.1 .ASCUS is 
4.6,  LSIL  is  4.8,  HSIL  is  4.9,  SCC  is  5.8,  atypicalendocervical  cells  is 
4.8  atypical  endocervical  cells  favour  neoplastic  is  5.5  and  endocervical 
adenocarcinoma in situ is 7.1. Malignant cases have higher AgNOR than reactive 
cases. 
In a study by J.J.Misra et al, there was a progressive increase in AgNOR 
count when the severity of the lesion was increased. The statistical analysis show 
p value<0.05 between normal and inflammatory lesions. And highly significant 
difference between inflammatory and LSIL cases, between LSIL and HSIL and 
between  severe  dysplasia  and  frankly  malignant  cases.  (p<0.01)  Eagan  et  al 
observed that mean AgNOR count increased steadily whereas the mean size of 
AgNORs decreased from CIN I to CIN II32.
 Cardillo  studied  AgNOR  counts  in  cervical  smears  of  squamous 
metaplasia and cervical intra epithelial neoplasia. The smears previously stained 
with Papanicolaou technique were destained and restained with AgNOR silver. 
He  found  statistically  significant  difference  (p  <  0.05)  in  AgNOR counts  in 
squamous metaplasia and various grades of CIN47.
AGNOR STAINING IN HPE
In our study there is no significant difference in AgNOR counts between 
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squamous metaplasia and chronic cervicitis. The mean number of AgNORs per 
nucleus is significantly higher in dysplasia (mild 4.9, moderate 5, severe 5.5) and 
malignant lesions (squamous cell carcinoma 6, adenocarcinoma 6.4) as compared 
to metaplasia 3.3 and chronic cervicitis 3.2. All carcinomas and severe dysplasia 
have  significantly  higher  AgNOR  counts  per  nucleus  compared  to  mild 
dysplasia.  NOR  counts  are  higher  in  adenocarcinoma  when  compared  to 
squamous  cell  carcinoma.  Statistical  analysis  reveals  significant  difference 
between mean AgNOR counts of chronic cervicitis and dysplasia; mild dysplasia 
and severe dysplasia,  severe dysplasia and invasive carcinoma, squamous cell 
carcinoma and adeno carcinoma.
Overall the mean AgNOR counts for carcinoma cervix are increased from 
chronic cervicitis and dysplasia.
An Indian study done by Prathiba and Kuruvilla  (1995) on the role of 
AgNOR  in  diagnosis  of  premalignant  and  malignant  lesions  of  the  cervix, 
showed that mean AgNOR count progressively increased from normal to CIN I, 
CIN II, CIN III and invasive carcinoma. The difference between counts in CIN I 
and CIN II and invasive carcinoma was statistically significant27.
Crocker et al in 1990 also showed statistically significant difference in 
AgNOR counts between CIN I, CIN II and CIN III36. The table 13 shows mean 
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AgNOR counts in various grades in different studies.
In  Jyomita  Agarwal,  JK Gupta  study (1997)  AgNORs was counted in 
biopsies  from 202 cases  of  various  lesions  and cervix.  The  mean number of 
AgNORs  per  nucleus  was  significantly  higher  in  CIN  (4.05±0.04)  and 
Malignancy (5.50±0.65) as compared to squamous metaplasia (1.74±0.32) and 
chronic cervicitis (1.54±0.42). Adeno carcinomas had higher AgNOR counts as 
compared to other carcinomas. It concluded that the estimation of AgNORs can 
be  helpful  in  distinguishing  benign  lesions  from CIN and malignancy  of  the 
cervix29.
In Rajni Kaushik, study, the mean AgNOR counts in cervical epithelium 
showed a progressive and statistically significant increase from normal to chronic 
cervicitis to CIN I, II and III (p < 0.001). Scores in carcinoma also exceeded that 
of CIN (p < 0.05).  It  concluded that this can prove to be a useful adjunct to 
routine histopathology to evaluate cervical lesions34.
In our study also, it is noted that the size of AgNOR dots decrease with 
increase  in  AgNOR count.  This  is  in  accordance  with  the  study reported  by 
Eagan who noted an inverse relationship between AgNOR numbers and sizes, 
and proved that severe dysplasia could be distinguished from mild dysplasia on 
the basis of AgNOR size48.
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SUMMARY
The present correlative study revealed the following:
1. The  peak  age  incidence  of  reactive  lesions  is  fourth  decade  while 
premalignant and malignant lesions are fifth decade and above.
2. The  earlier  the  age  at  marriage,  they  are  more  vulnerable  to  cervical 
lesions especially malignant. 
3. The severity of cervical lesions increases with parity. 
4. The  most  common finding  in  The  Bethesda  System (TBS)  is  reactive 
cellular  changes  accounting  for  36.4%  in  cytology  and  44.1%  in 
histopathology. 
5. When the 53 ASCUS category smears of TBS were followed up in HPE, 8 
(15.1%) preinvasive lesions were detected. 
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6. Among the malignant lesions, the incidence of squamous cell carcinoma is 
high accounting for 20% in cytology and 32.1% in histopathology. 
7. The  overall  sensitivity  of  Pap  smear  is  90%,  specificity  is  80%  and 
accuracy is 90%. 
8. The AgNOR count in Pap smear is higher in malignant cases than the 
reactive lesions in Pap smear. 
9. The AgNOR count  in  premalignant  lesions  is  higher  than the  reactive 
lesions in Pap smear. 
10.Histopathological examination of the cervix is the gold standard against 
which the accuracy of Pap smear can be obtained and is found to be 90% 
in this study.  
11.The AgNOR count in histopathological examination which reflects the 
behaviour of cells is higher that is 4.9 in mild dysplasia,  5.5 in severe 
dysplasia with carcinoma in situ in this study when compared to chronic 
cervicitis 3.2 and squamous metaplasia 3.3.  
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12.Adenocarcinoma  has  higher  AgNOR  count  (6.4)  than  squamous  cell 
carcinoma (6.0).
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CONCLUSION
In conclusion, this correlative study of Pap smear and histopathological 
examination of cervix revealed the overall sensitivity of 90%, specificity of 80% 
and accuracy of 90%.
The false negative and false positive cases in this study can be minimized 
by  proper  sampling,  screening,  interpretation  and  further  follow  up  study  of 
repeat smears.
AgNOR  stain  and  count  in  routine  Pap  smear  and  histopathological 
examination of cervix are found to be simple and useful adjuvant test particularly 
in the dysplastic lesions.
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ANNEXURE – I
PROFORMA
1. Name :
2. Age :
3. Address :
4. Unit :
5. OP/IP Number :
6. Cytology Number :
7. Menstrual History :
Menarche -
Menstrual cycle -
8. Marital Status :
Age at Marriage   
9. Obstetrical history :
Number of children 
Last child birth 
Sterilized or not 
Any other method of contraception 
10. Presenting Symptoms Duration 
White discharge –
Bleeding per vaginum 
Mass decending per vaginum 
Abdominal pain – 
11. Clinical diagnosis :
12. Pap smear report :
      i) TBS
* Unsatisfactory – 
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* Satisfactory -
(1) Negative for intra epithelial lesion - 
Trichomonas Vaginalis 
Fungus – Candia 
Actionmyces 
Herpes Simplex 
Nonneoplastic Lesions 
Reactive cellular changes 
Glandular Cells 
Atrophy 
Endometrial cells 
(2) Epithelial Cell Abnormalities 
Atypical squamous cell of undetermined significance (ASC-US)
Low – grade squamous intra epithelial lesion (LSIL)
High – grade squamous intra epithelial lesion (HSIL)
Squamous cell carcinoma 
Atypical end cervical cells 
Atypical endometrial cells 
Atypical endocervical cells favour neoplastic 
    (ii) BY C.I.N. (WHO) :     Grade I (Mild)
      Grade II (Moderate)
      Grade III (Severe+ Ca in situ)  
            And above
13. Biopsy Report :
14. AgNOR :
Cytology :
H.P.E
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